JTC Employer Solutions Trustee »

Adaptimmune Therapeutics shares owned by JTC Employer Solutions Trustee

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by JTC Employer Solutions Trustee from 13F filings

Historical chart of JTC Employer Solutions Trustee investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by JTC Employer Solutions Trustee consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by JTC Employer Solutions Trustee

Quarter filed Position value Share count Share price at filing
2024-03-31 $41k 26k 1.57

More positions owned by JTC Employer Solutions Trustee

GSK Sponsored Adr (GSK)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Union Pacific Corporation (UNP)
Ishares Tr Core S&p500 Etf (IVV)
Costco Wholesale Corporation (COST)
Apple (AAPL)
American Intl Group Com New (AIG)
NVIDIA Corporation (NVDA)
Bank of America Corporation (BAC)
Citigroup Com New (C)
Amazon (AMZN)
Ishares Tr Broad Usd High (USHY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)

View all positions for JTC Employer Solutions Trustee

Top funds holding Adaptimmune Therapeutics

NEA Management Company
Baillie Gifford & Co
Long Focus Capital Management
Baker Bros. Advisors
Partner Fund Management
Bank of America Corporation
Tang Capital Management
Citadel Advisors
Syncona Portfolio
Jpmorgan Chase & Co
Redmile Group
Acuitas Investments
Millennium Management
GSA Capital Partners
DAFNA Capital Management

View all funds holding Adaptimmune Therapeutics